PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $5,175,000 | -68.5% | 176,202 | -17.9% | 0.01% | -69.0% |
Q4 2015 | $16,434,000 | -7.4% | 214,746 | -8.8% | 0.03% | -12.1% |
Q3 2015 | $17,749,000 | +14.8% | 235,533 | +77.9% | 0.03% | +32.0% |
Q2 2015 | $15,459,000 | +993.3% | 132,412 | +2109.4% | 0.02% | +733.3% |
Q1 2015 | $1,414,000 | +33.9% | 5,993 | +7.6% | 0.00% | +50.0% |
Q4 2014 | $1,056,000 | +13.3% | 5,570 | +42.6% | 0.00% | 0.0% |
Q3 2014 | $932,000 | +47.5% | 3,906 | +34.7% | 0.00% | +100.0% |
Q2 2014 | $632,000 | +857.6% | 2,900 | +227.7% | 0.00% | – |
Q1 2014 | $66,000 | -74.4% | 885 | -81.6% | 0.00% | – |
Q3 2013 | $258,000 | +24.0% | 4,816 | +2.5% | 0.00% | – |
Q2 2013 | $208,000 | – | 4,698 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 507,500 | $121,074,000 | 24.90% |
BB BIOTECH AG | 476,991 | $113,796,000 | 4.63% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $1,356,668,000 | 3.35% |
WEATHERBIE CAPITAL, LLC | 101,055 | $24,109,000 | 2.26% |
Avalon Global Asset Management LLC | 16,000 | $3,817,000 | 2.24% |
Redmile Group, LLC | 51,025 | $12,173,000 | 1.41% |
Fernwood Investment Management, LLC | 6,700 | $1,598,000 | 1.38% |
Iguana Healthcare Management, LLC | 10,000 | $2,386,000 | 1.27% |
LMR Partners LLP | 56,632 | $13,510,000 | 1.08% |
FRANKLIN STREET ADVISORS INC /NC | 21,990 | $5,246,000 | 1.00% |